Výsledky vyhledávání - "Anna Bassini"

Akademický článek

Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study

Autor: Francesco Schettini, Silvana Saracchini, Anna Bassini, Wally Marus, Serena Corsetti, Ilaria Specogna, Manuela Bertola, Elvia Micheli, Ralph M. Wirtz, Mark Laible, Uğur Şahin, Carla Strina, Manuela Milani, Sergio Aguggini, Richard Tancredi, Elena Fiorio, Sandro Sulfaro, Daniele Generali

Publikováno v: Breast, Vol 76, Iss , Pp 103753- (2024)

Background: Neoadjuvant chemotherapy (NACT) is widely used in the treatment of triple-negative and HER2-positive breast cancer (BC), but its use in estrogen receptor (ER) and/or progesterone receptor (PR) positive/HER2-negative BC is questioned becau

Externí odkaz: https://doaj.org/article/685e98291b35410783bf6f6dcacb65bd

Zobrazit plný text záznamu

Abstract P1-10-23: Prediction of pathological complete response (pCR) upon neoadjuvant chemotherapy by MammaTyper® pCR score

Autor: Wally Marus, Daniele Generali, Ralph M. Wirtz, Anna Bassini, Mark Laible, Ilaria Specogna, Manuela Bertola, Ugur Sahin, Sandro Sulfaro, Elvia Micheli, Saracchini S, Serena Corsetti

Publikováno v: Cancer Research. 80:P1-10

Background: Neoadjuvant chemotherapy (NACT) (+/- anti HER2) is the preferred therapy for triple negative and HER2 positive subtype breast tumors. In Luminal subtype breast tumors, NACT is used to downstage large inoperable tumors and enable breast co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce18c1a8bd412091e5ecda3556b37135
https://doi.org/10.1158/1538-7445.sabcs19-p1-10-23

Zobrazit plný text záznamu

Adolescent with right axillary swelling

Autor: Roberto Dall'Amico, Anna Bassini, Veronica Guastalla, Andrea Trombetta, Federica Pederiva

Publikováno v: Journal of Paediatrics and Child Health.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f4f20e637894c7a55ce3fba7da0086
https://doi.org/10.1111/jpc.15320

Zobrazit plný text záznamu

Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplification

Autor: M. Gion, Anna Bassini, F. Tuccia, A. Del Conte, Elvia Micheli, Luisa Foltran, Silvana Saracchini, Manuela Bertola, M. Lorenzon, Sandro Sulfaro, Salvatore Tumolo

Publikováno v: The Breast. 22:1101-1107

Purpose of the study Trastuzumab combined with sequential chemotherapy with taxanes and anthracyclines as primary systemic therapy achieved high rates of pathologic complete response (pCR). Non-pegylated liposome-encapsulated doxorubicin (NPLD) has s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b574316e4fbd3b89dababe530504f1d
https://doi.org/10.1016/j.breast.2013.09.001

Zobrazit plný text záznamu

Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma

Autor: Franca Riosa, Piernicola Machin, Carla Di Loreto, Enrico Pegolo, Anna Bassini, Laura Deroma

Publikováno v: Cancer Cytopathology. 120:196-205

BACKGROUND: Fine-needle aspiration cytology (FNAC) is a well-accepted procedure for the diagnosis and biological characterization of breast carcinoma. Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0998299c5dffd5db821bc1e522aafb03
https://doi.org/10.1002/cncy.20206

Zobrazit plný text záznamu

Neoadjuvant chemotherapy with nonpegylated liposome-encapsulated doxorubicin (NPLD) plus cyclophosphamide followed by trastuzumab plus nabpaclitaxel for HER2-positive breast cancer (BC)

Autor: Anna Bassini, Michele Lorenzon, Salvatore Tumolo, Stefania Manente, Alessandro Favero, Luisa Foltran, Elvia Micheli, Silvana Saracchini, Alessandro Del Conte, Wally Marus, Sandro Sulfaro, Giuseppina Gusso

Publikováno v: Journal of Clinical Oncology. 32:648-648

648 Background: Using a liposomal delivery system NPLD has shown similar efficacy and less cardiac toxicity compared to conventional anthracyclines. Similarly albumin-bound paclitaxel (nabpaclitaxe...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb7c6f2a993e564ee33fbbaf84e9173b
https://doi.org/10.1200/jco.2014.32.15_suppl.648

Zobrazit plný text záznamu

Liposome-encapsulated doxorubicin plus cyclophosphamide followed by trastuzumab plus docetaxel as neoadjuvant therapy for HER2-positive breast cancer (BC): A multicenter single-arm phase II study

Autor: Manuela Bertola, Alessandro Del Conte, Fausto Tuccia, Tania Baresic, Salvatore Tumolo, Anna Bassini, Elvia Micheli, Giuseppina Gusso, Stefania Manente, Luisa Foltran, Silvana Saracchini, Sandro Sulfaro

Publikováno v: Publons

641 Background: Trastuzumab combined to sequential chemotherapy with taxanes and anthracyclines as primary treatment achieved high rates of pathologic complete response (pCR) in HER2 positive BC. Liposome-encapsulated doxorubicin (DLNP) shown equal e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b335047d7ff04444235e70cd516ce735
https://doi.org/10.1200/jco.2013.31.15_suppl.641

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání